New coated balloon fights heart stent reblocking
NCT ID NCT05731700
Summary
This first-in-human study tested a special balloon catheter coated with the drug everolimus to treat arteries that had narrowed again after a previous stent placement. The study involved 51 participants with re-narrowed coronary stents to assess safety and whether the coated balloon could prevent the artery from re-narrowing. Researchers followed participants for 180 days to measure artery opening and track complications like heart attacks or need for repeat procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IN-STENT RESTENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinique Pasteur
Toulouse, 31300, France
-
Georgian Israeli Research Medical Centre Helsicore
Tbilisi, Georgia
-
Groupe Hospitalier Mutualiste de Grenoble
Grenoble, 38000, France
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario de La Princesa
Madrid, 28006, Spain
-
L'Hôpital Privé du Confluent
Nantes, 44000, France
-
Tbilisi Heart and Vascular Clinic
Tbilisi, 0159, Georgia
-
Vilniaus universiteto ligoninė Santaros klinikos
Vilnius, 08410, Lithuania
Conditions
Explore the condition pages connected to this study.